HRT Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

HRT Financial’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.1M	Buy	40,533 +13,743	+51%	+$6.09M	0.04%	478
2026 Q1	$12M	Buy	+26,790	New	+$12.5M	0.03%	551
2025 Q1	–	Sell	-10,030	Closed	-$4.04M	–	3466
2024 Q4	$4.04M	Sell	10,030 -33,267	-77%	-$15.4M	0.02%	466
2024 Q3	$20.1M	Sell	43,297 -80,212	-65%	-$38.5M	0.1%	122
2024 Q2	$57.9M	Buy	+123,509	New	+$53.6M	0.32%	39
2024 Q1	–	Sell	-7,948	Closed	-$3.23M	–	3168
2023 Q4	$3.23M	Buy	7,948 +5,406	+213%	+$2M	0.02%	455
2023 Q3	$883K	Sell	2,542 -1,272	-33%	-$445K	0.01%	1062
2023 Q2	$1.34M	Buy	+3,814	New	+$1.29M	0.01%	778
2022 Q1	–	Sell	-63,603	Closed	-$15.1M	–	3942
2021 Q4	$14M	Buy	+63,603	New	+$12.4M	0.08%	121
2021 Q3	–	Sell	-6,834	Closed	-$1.38M	–	3804
2021 Q2	$1.38M	Sell	6,834 -25,442	-79%	-$5.32M	0.01%	823
2021 Q1	$6.93M	Buy	+32,276	New	+$7.09M	0.07%	202
2019 Q4	–	Sell	-9,191	Closed	-$1.56M	–	1683
2019 Q3	$1.56M	Buy	+9,191	New	+$1.63M	0.07%	237
2019 Q2	–	Sell	-7,768	Closed	-$1.43M	–	929
2019 Q1	$1.43M	Buy	+7,768	New	+$1.43M	0.22%	63
2018 Q3	–	Sell	-5,368	Closed	-$912K	–	511
2018 Q2	$912K	Buy	5,368 +3,443	+179%	+$534K	0.33%	47
2018 Q1	$313K	Buy	+1,925	New	+$314K	0.15%	129
2015 Q4	–	Sell	-2,584	Closed	-$269K	–	119
2015 Q3	$269K	Buy	+2,584	New	+$332K	0.23%	58

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HRT Financial's VRTX Position: Q2 2026 in Review

HRT Financial increased its Vertex Pharmaceuticals (VRTX) stake by 51% in Q2 2026, buying an estimated $6.09M and bringing the position to 40,533 shares worth $20.1M. The position accounts for 0.04% of the portfolio, ranked #478.

HRT Financial first reported a position in VRTX in Q3 2015 and has held it in 16 quarters since. The position peaked at $57.9M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

HRT Financial held 40,533 shares of Vertex Pharmaceuticals worth $20.1M as of Q2 2026.
HRT Financial bought 13,743 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.09M.
Vertex Pharmaceuticals made up 0.04% of HRT Financial's portfolio in Q2 2026, its #478 holding.
HRT Financial first reported a position in Vertex Pharmaceuticals in Q3 2015 and has held it in 16 quarters since.
HRT Financial's Vertex Pharmaceuticals position peaked at $57.9M in Q2 2024.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.